Pursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Nectar Lifesciences has informed that it enclosed copy of Annual Report for the financial year ended on March 31, 2022, containing therein: Notice of 27th Annual General Meeting (AGM), Standalone Financial Statements, Directors and Auditors Report thereon, Consolidated Financial Statements and Auditors Report thereon, Corporate Governance Report, Management Discussion and Analysis Report along with Attendance Slip and E-voting Instructions. The above details are also available on the website of the Company. Consequent to resignation of Sanjit Singh Lamba, he is not being proposed to be appointed as a regular director as well as Wholetime Director in the AGM.
The above information is a part of company’s filings submitted to BSE.
